Insurance and pharmaceutical companies are increasingly signing contracts linking a products performance to its price. Though this is not a solution to the pharmaceutical pricing problems we currently face, it is a step in the right direction. Read more here. (Source: David brooks, Granite geek,4/6/17)
You are here: Home / Evidenced Based Medicine / When Pharmaceutical Pricing Meets Evidence-based Medicine
